-
Je něco špatně v tomto záznamu ?
End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade
Z. Vernerová, P. Kujal, H. J. Kramer, A. Bäcker, L. Červenka, I. Vaněčková
Jazyk angličtina Země Česko
Typ dokumentu přehledy
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- angiotensin II metabolismus MeSH
- financování organizované MeSH
- hypertenze etiologie metabolismus patofyziologie MeSH
- krevní tlak MeSH
- kuchyňská sůl škodlivé účinky MeSH
- ledviny metabolismus patofyziologie MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- oxid dusnatý metabolismus MeSH
- oxidační stres MeSH
- renin-angiotensin systém MeSH
- sodík metabolismus MeSH
- superoxidy metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- přehledy MeSH
Renin-angiotensin system (RAS) plays a key role in the regulation of renal function, volume of extracellular fluid and blood pressure. The activation of RAS also induces oxidative stress, particularly superoxide anion (O(2)(-)) formation. Although the involvement of O(2)(-) production in the pathology of many diseases is known for long, recent studies also strongly suggest its physiological regulatory function of many organs including the kidney. However, a marked accumulation of O(2)(-) in the kidney alters normal regulation of renal function and thus may contribute to the development of salt-sensitivity and hypertension. In the kidney, O(2)(-) acts as vasoconstrictor and enhances tubular sodium reabsorption. Nitric oxide (NO), another important radical that exhibits opposite effects than O(2)(-), is also involved in the regulation of kidney function. O(2)(-) rapidly interacts with NO and thus, when O(2)(-) production increases, it diminishes the bioavailability of NO leading to the impairment of organ function. As the activation of RAS, particularly the enhanced production of angiotensin II, can induce both O(2)(-) and NO generation, it has been suggested that physiological interactions of RAS, NO and O(2)(-) provide a coordinated regulation of kidney function. The imbalance of these interactions is critically linked to the pathophysiology of salt-sensitivity and hypertension.
Citace poskytuje Crossref.org
Lit.: 35
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10013405
- 003
- CZ-PrNML
- 005
- 20151006141143.0
- 008
- 100604s2009 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931640 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Vernerová, Zdenka, $d 1960-2020 $7 jo2002104672
- 245 10
- $a End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade / $c Z. Vernerová, P. Kujal, H. J. Kramer, A. Bäcker, L. Červenka, I. Vaněčková
- 314 __
- $a Center for Cardiovascular Research, Prague likp@ikem.cz
- 504 __
- $a Lit.: 35
- 520 9_
- $a Renin-angiotensin system (RAS) plays a key role in the regulation of renal function, volume of extracellular fluid and blood pressure. The activation of RAS also induces oxidative stress, particularly superoxide anion (O(2)(-)) formation. Although the involvement of O(2)(-) production in the pathology of many diseases is known for long, recent studies also strongly suggest its physiological regulatory function of many organs including the kidney. However, a marked accumulation of O(2)(-) in the kidney alters normal regulation of renal function and thus may contribute to the development of salt-sensitivity and hypertension. In the kidney, O(2)(-) acts as vasoconstrictor and enhances tubular sodium reabsorption. Nitric oxide (NO), another important radical that exhibits opposite effects than O(2)(-), is also involved in the regulation of kidney function. O(2)(-) rapidly interacts with NO and thus, when O(2)(-) production increases, it diminishes the bioavailability of NO leading to the impairment of organ function. As the activation of RAS, particularly the enhanced production of angiotensin II, can induce both O(2)(-) and NO generation, it has been suggested that physiological interactions of RAS, NO and O(2)(-) provide a coordinated regulation of kidney function. The imbalance of these interactions is critically linked to the pathophysiology of salt-sensitivity and hypertension.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a angiotensin II $x metabolismus $7 D000804
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze $x etiologie $x metabolismus $x patofyziologie $7 D006973
- 650 _2
- $a ledviny $x metabolismus $x patofyziologie $7 D007668
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a renin-angiotensin systém $7 D012084
- 650 _2
- $a sodík $x metabolismus $7 D012964
- 650 _2
- $a kuchyňská sůl $x škodlivé účinky $7 D017673
- 650 _2
- $a superoxidy $x metabolismus $7 D013481
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kujal, Petr. $7 xx0244311
- 700 1_
- $a Kramer, Herbert J. $7 xx0085908
- 700 1_
- $a Bäcker, Angela $7 xx0085909
- 700 1_
- $a Červenka, Luděk, $d 1967- $7 xx0037105
- 700 1_
- $a Vaněčková, Ivana, $d 1964- $7 xx0030586
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 58,Suppl. 2 (2009), s. S69 - S78 $x 0862-8408
- 773 0_
- $t Center for cardiovascular research $g Roč. 58,Suppl. 2 (2009), s. S69 - S78 $w MED00173857
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/58%20Suppl%202/58_S69.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8 $z 0
- 990 __
- $a 20100603155515 $b ABA008
- 991 __
- $a 20151006141328 $b ABA008
- 999 __
- $a ok $b bmc $g 749266 $s 612906
- BAS __
- $a 3
- BMC __
- $a 2009 $b 58 $c Suppl. 2 $d S69 - S78 $m Physiological research $x MED00003824
- BMC __
- $a 2009 $b 58 $c Suppl. 2 $d S69 - S78 $m Center for cardiovascular research $x MED00173857
- LZP __
- $a 2010-15/mkme